MYOTONACHOL Drug Patent Profile
✉ Email this page to a colleague
When do Myotonachol patents expire, and what generic alternatives are available?
Myotonachol is a drug marketed by Glenwood and is included in one NDA.
The generic ingredient in MYOTONACHOL is bethanechol chloride. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Myotonachol
A generic version of MYOTONACHOL was approved as bethanechol chloride by UPSHER SMITH LABS on June 1st, 2005.
Summary for MYOTONACHOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Patent Applications: | 1,356 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MYOTONACHOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MYOTONACHOL
US Patents and Regulatory Information for MYOTONACHOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenwood | MYOTONACHOL | bethanechol chloride | TABLET;ORAL | 084188-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenwood | MYOTONACHOL | bethanechol chloride | TABLET;ORAL | 084188-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenwood | MYOTONACHOL | bethanechol chloride | TABLET;ORAL | 084188-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |